An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy - Safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy(ALCT002)

Department of Respiratory Medicine Kyorin Univercity Hospital0 个研究点目标入组 60 人开始时间: 2012年5月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients with the serum creatinine level exceeding the upper limit of the hospital or with the estimated Ccr of 60mL/min or lower 2. Patients with intractable ascites or pleural effusion except those who have been treated by pleurodesis. 3. Patients with psychiatric disease or psychological symptom 4. Female patients of childbearing potential, pregnancy, or lactation 5. Patients with poorly controlled diabetes 6. Patients who meet the criteria specified in "contraindication" or "careful administration" in the package inserts of the intravenous solutions used in the study 7. Patients with difficulty eating or with grade 2 or higher anorexia (CTCAE 4.0) 8. Patients otherwise deemed unsuitable for inclusion in the study for any other reason based on the assessment by the investigator

发起方

Department of Respiratory Medicine Kyorin Univercity Hospital